336 related articles for article (PubMed ID: 16487557)
41. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
[TBL] [Abstract][Full Text] [Related]
42. Effects of acute changes of bile acid pool composition on biliary lipid secretion.
Carulli N; Loria P; Bertolotti M; Ponz de Leon M; Menozzi D; Medici G; Piccagli I
J Clin Invest; 1984 Aug; 74(2):614-24. PubMed ID: 6746909
[TBL] [Abstract][Full Text] [Related]
43. Increased sulfation and decreased 7alpha-hydroxylation of deoxycholic acid in ethinyl estradiol-induced cholestasis in rats.
Jensen RT; Davis RA; Kern F
Gastroenterology; 1977 Aug; 73(2):314-20. PubMed ID: 873132
[TBL] [Abstract][Full Text] [Related]
44. Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling.
Cipriani S; Renga B; D'Amore C; Simonetti M; De Tursi AA; Carino A; Monti MC; Sepe V; Zampella A; Fiorucci S
PLoS One; 2015; 10(7):e0129866. PubMed ID: 26177448
[TBL] [Abstract][Full Text] [Related]
45. Synergistic role of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7alpha-hydroxylase in the pathogenesis of manganese-bilirubin-induced cholestasis in rats.
Akoume MY; Perwaiz S; Yousef IM; Plaa GL
Toxicol Sci; 2003 Jun; 73(2):378-85. PubMed ID: 12700418
[TBL] [Abstract][Full Text] [Related]
46. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes.
Bouchard G; Yousef IM; Tuchweber B
Liver; 1993 Aug; 13(4):193-202. PubMed ID: 8377596
[TBL] [Abstract][Full Text] [Related]
47. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
Roda E; Mazzella G; Bazzoli F; Villanova N; Minutello A; Simoni P; Ronchi M; Poggi C; Festi D; Aldini R
Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
[TBL] [Abstract][Full Text] [Related]
48. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
[TBL] [Abstract][Full Text] [Related]
49. Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis.
Scharschmidt BF; Lake JR
Dig Dis Sci; 1989 Dec; 34(12 Suppl):5S-15S. PubMed ID: 2689116
[TBL] [Abstract][Full Text] [Related]
50. Biliary lipid output in the early stage of acute liver failure induced by 90% hepatectomy in the rat.
Tanaka S; Chijiiwa K; Maeda Y
J Surg Res; 2006 Jul; 134(1):81-6. PubMed ID: 16464471
[TBL] [Abstract][Full Text] [Related]
51. Cholestatic effect of epigallocatechin gallate in rats is mediated via decreased expression of Mrp2.
Hirsova P; Karlasova G; Dolezelova E; Cermanova J; Zagorova M; Kadova Z; Hroch M; Sispera L; Tomsik P; Lenicek M; Vitek L; Pavek P; Kucera O; Cervinkova Z; Micuda S
Toxicology; 2013 Jan; 303():9-15. PubMed ID: 23146761
[TBL] [Abstract][Full Text] [Related]
52. Beneficial effects of colchicine on 17alpha-ethynylestradiol-induced cholestasis in rats.
Zhou ZX; Wang T; Jiang ZZ; Shang J; Liu L; Zhang Y; Zhu D; Huang X; Zhang S; Hu Y; Wang JY; Zhang LY
Arzneimittelforschung; 2011; 61(3):173-9. PubMed ID: 21528642
[TBL] [Abstract][Full Text] [Related]
53. MDR1 substrates/modulators protect against beta-estradiol-17beta-D-glucuronide cholestasis in rat liver.
Liu Y; Huang L; Hoffman T; Gosland M; Vore M
Cancer Res; 1996 Nov; 56(21):4992-7. PubMed ID: 8895755
[TBL] [Abstract][Full Text] [Related]
54. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
Chretien Y; Poupon R; Gherardt MF; Chazouilleres O; Labbe D; Myara A; Trivin F
Gut; 1989 Aug; 30(8):1110-5. PubMed ID: 2767508
[TBL] [Abstract][Full Text] [Related]
55. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.
Rudolph G; Kloeters-Plachky P; Sauer P; Stiehl A
Eur J Clin Invest; 2002 Aug; 32(8):575-80. PubMed ID: 12190957
[TBL] [Abstract][Full Text] [Related]
56. Tauro-beta-muricholate preserves choleresis and prevents taurocholate-induced cholestasis in colchicine-treated rat liver.
Katagiri K; Nakai T; Hoshino M; Hayakawa T; Ohnishi H; Okayama Y; Yamada T; Ohiwa T; Miyaji M; Takeuchi T
Gastroenterology; 1992 May; 102(5):1660-7. PubMed ID: 1568576
[TBL] [Abstract][Full Text] [Related]
57. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Pojer C; Zenz R; Lammert F; Stieger B; Meier PJ; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2001 Jul; 121(1):170-83. PubMed ID: 11438506
[TBL] [Abstract][Full Text] [Related]
58. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
[TBL] [Abstract][Full Text] [Related]
59. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
Stiehl A; Rudolph G; Sauer P; Theilmann L
J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
[TBL] [Abstract][Full Text] [Related]
60. delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism.
Setchell KD; Yamashita H; Rodrigues CM; O'Connell NC; Kren BT; Steer CJ
Biochemistry; 1995 Apr; 34(13):4169-78. PubMed ID: 7703228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
